[go: up one dir, main page]

WO2002018414A3 - Haplotypes of the bf gene - Google Patents

Haplotypes of the bf gene Download PDF

Info

Publication number
WO2002018414A3
WO2002018414A3 PCT/US2001/027098 US0127098W WO0218414A3 WO 2002018414 A3 WO2002018414 A3 WO 2002018414A3 US 0127098 W US0127098 W US 0127098W WO 0218414 A3 WO0218414 A3 WO 0218414A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
haplotypes
disclosed
properdin
haplotyping
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/027098
Other languages
French (fr)
Other versions
WO2002018414A2 (en
Inventor
Alison E Anastasio
Kevin Finkel
Amir Kazemi
Beena Koshy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2001286949A priority Critical patent/AU2001286949A1/en
Publication of WO2002018414A2 publication Critical patent/WO2002018414A2/en
Publication of WO2002018414A3 publication Critical patent/WO2002018414A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Novel genetic variants of the B-Factor, Properdin (BF) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the BF gene. Compositions and methods for haplotyping and/or genotyping the BF gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.
PCT/US2001/027098 2000-08-29 2001-08-29 Haplotypes of the bf gene Ceased WO2002018414A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001286949A AU2001286949A1 (en) 2000-08-29 2001-08-29 Haplotypes of the bf gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22894000P 2000-08-29 2000-08-29
US60/228,940 2000-08-29

Publications (2)

Publication Number Publication Date
WO2002018414A2 WO2002018414A2 (en) 2002-03-07
WO2002018414A3 true WO2002018414A3 (en) 2003-02-06

Family

ID=22859176

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/027098 Ceased WO2002018414A2 (en) 2000-08-29 2001-08-29 Haplotypes of the bf gene

Country Status (2)

Country Link
AU (1) AU2001286949A1 (en)
WO (1) WO2002018414A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10053734B2 (en) 2009-10-07 2018-08-21 Genentech, Inc. Methods for treating, diagnosing, and monitoring lupus

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012683B2 (en) 2006-02-13 2011-09-06 University Of Iowa Research Foundation Variants in complement regulatory genes predict age-related macular degeneration
WO2007120975A2 (en) * 2006-02-13 2007-10-25 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Variants in complement regulatory genes predict age-related macular degeneration
DK3533882T3 (en) * 2013-10-15 2022-12-19 Illumina Inc SINGLE NUCLEOTIDE POLYMORPHISM IN MAJOR HISTOCOMPATIBILITY COMPLEX

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MEJIA J.E. ET AL.: "Human factor B: Complete cDNA sequence of the BF*S allele", HUMAN IMMUNOLOGY, vol. 39, no. 1, 1994, pages 49 - 53, XP002952037 *
WOODS D.E. ET AL.: "Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product", PROC. NATL. ACAD. SCI. USA, vol. 79, no. 18, September 1982 (1982-09-01), pages 5661 - 5665, XP002952036 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10053734B2 (en) 2009-10-07 2018-08-21 Genentech, Inc. Methods for treating, diagnosing, and monitoring lupus

Also Published As

Publication number Publication date
AU2001286949A1 (en) 2002-03-13
WO2002018414A2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
WO2002006294A3 (en) Haplotypes of the mmp13 gene
WO2002018414A3 (en) Haplotypes of the bf gene
WO2001079234A3 (en) Haplotypes of the apoe gene
WO2002008425A3 (en) Haplotypes of the adrb3 gene
WO2002010454A3 (en) Haplotypes of the alas2 gene
WO2002090512A3 (en) Haplotypes of the nnmt gene
WO2001090127A3 (en) Haplotypes of the hoxd3 gene
WO2002012498A3 (en) Haplotypes of the isl1 gene
WO2001087909A3 (en) Haplotypes of the aanat gene
WO2002040502A3 (en) Haplotypes of the lipe gene
WO2002040503A3 (en) Haplotypes of the plau gene
WO2002038586A3 (en) Haplotypes of the il6 gene
WO2002042320A3 (en) Haplotypes of the gsr gene
WO2002050098A3 (en) Haplotypes of the prlr gene
WO2002012562A3 (en) Haplotypes of the pla2g1b gene
WO2001090120A3 (en) Haplotypes of the evx1 gene
WO2002012499A3 (en) Haplotypes of the ntf3 gene
WO2002090378A3 (en) Haplotypes of the ces2 gene
WO2002044201A3 (en) Haplotypes of the sah gene
WO2001090126A3 (en) Haplotypes of the snap29 gene
WO2002030950A3 (en) Haplotypes of the fy gene
WO2002055534A3 (en) Haplotypes of the f2rli gene
WO2001094362A3 (en) Haplotypes of the acp2 gene
WO2001090118A3 (en) Haplotypes of the edn2 gene
WO2001092278A3 (en) Haplotypes of the rlbp1 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP